Atlas Trials

Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome

Clinical trial NCT05875948 · UNKNOWN

Trial details

NCT number
NCT05875948
Sponsor
River 2 Renal Corp.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatorenal SyndromeAcute Kidney Injury
Start date
2023-06-30
Primary completion
2024-12-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.